The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 29, No. 12, pp. 1235-1237.
© 1995 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conesa, D
Right arrow Articles by Ferreres, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conesa, D
Right arrow Articles by Ferreres, J.

Research Articles

Invasive aspergillosis: a life-threatening complication of short-term steroid treatment

D Conesa, J Rello, J Valles, D Mariscal, and JC Ferreres

OBJECTIVE: To describe a patient with invasive pulmonary aspergillosis related to short-term steroid treatment. CASE SUMMARY: A 78-year-old man with chronic obstructive pulmonary disease (COPD) developed an invasive pulmonary aspergillosis after short-term (less than 1 week) intravenous steroid therapy. The diagnosis was established by recovering Aspergillus fumigatus from a bronchoalveolar lavage and was confirmed by autopsy, with the additional finding of an aspergilloma. DISCUSSION: This case is of interest for 3 reasons: (1) it illustrates that invasive aspergillosis may be followed by a rapidly progressive respiratory failure, even in the absence of a fever; (2) this patient had simultaneously an aspergilloma and an invasive aspergillosis; and (3) it confirms reports indicating that short-term steroid therapy for COPD represents a significant risk factor for opportunistic lung infections. CONCLUSIONS: In patients with COPD who receive even short-term steroid therapy and who have progressive respiratory failure caused by pneumonia, invasive aspergillosis should be suspected early and acted upon accordingly.


This article has been cited by other articles:


Home page
 Chronic Respiratory DiseaseHome page
P. Samarakoon and A. Soubani
Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature
Chronic Respiratory Disease, February 1, 2008; 5(1): 19 - 27.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
P. Bulpa, A. Dive, and Y. Sibille
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
Eur. Respir. J., October 1, 2007; 30(4): 782 - 800.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
S. Okada, S. Teramoto, H. Takizawa, Y. Ouchi, and R. Matsuoka
Clinical insignificance of (1<-3)-{beta}-D-glucan in early diagnosis of invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease
J. Med. Microbiol., November 1, 2003; 52(11): 1031 - 1032.
[Full Text] [PDF]

Home page
 ChestHome page
C. Agusti, A. Rano, X. Filella, J. Gonzalez, A. Moreno, A. Xaubet, and A. Torres
Pulmonary Infiltrates in Patients Receiving Long-term Glucocorticoid Treatment: Etiology, Prognostic Factors, and Associated Inflammatory Response
Chest, February 1, 2003; 123(2): 488 - 498.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. L. Kradin and E. J. Mark
Case 32-1998- An 83-Year-Old Woman with Long-Standing Asthma and Rapidly Progressing Pneumonia
N. Engl. J. Med., October 22, 1998; 339(17): 1228 - 1236.
[Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1995 by Harvey Whitney Books Company.